Literature DB >> 6181086

Elevation of serum angiotensin-converting enzyme activity in patients with hyperthyroidism.

Y Nakamura, T Takeda, M Ishii, K Nishiyama, M Yamakada, Y Hirata, K Kimura, S Murao.   

Abstract

The activity of serum angiotensin-converting enzyme (S-ACE) was determined spectrophotometrically in 45 patients with hyperthyroidism (30 untreated and 15 treated and euthyroid patients), 14 patients with hypothyroidism, and 135 normotensive healthy subjects. S-ACE was significantly higher in the patients with untreated hyperthyroidism (51.6 +/- 1.9 less than SE greater than nmol.min/ml) than in the healthy controls (28.6 +/- 0.6 nmol.min/ml; P less than 0.001). On the other hand, S-ACE was found to be within the normal range in patients with hypothyroidism (23.2 +/- 1.3 nmol.min/ml). In patients with hyperthyroidism, S-ACE gradually fell into the normal range as the thyroid function became normalized, and there were significant positive correlations between S-ACE and the plasma T3 or T4 concentration (r = 0.60 and P less than 0.001; r = 0.61 and P less than 0.001, respectively ). S-ACE had no definite relation to blood pressure, serum glutamic oxaloacetic acid transaminase, or glutamic pyruvic acid transaminase. When the physicochemical characteristics of the enzyme in the sera of hyperthyroidism patients were compared with those in sarcoidosis patients, similar peak activities of S-ACE on gel chromatography and identical Michaelis constants were obtained; the effects of ethyldiaminetetraacetic acid, SQ14225, and pH on the enzymatic reaction were also similar in both diseases. Thus, hyperthyroidism is considered to be one of the diseases in which S-ACE is elevated. The elevation of S-ACE might be directly or indirectly related to the hyperthyroid state. In addition, it is suggested that the enzyme characteristics are identical in hyperthyroidism and sarcoidosis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6181086     DOI: 10.1210/jcem-55-5-931

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

1.  Why is plasma angiotensin-converting enzyme activity elevated in hyperthyroidism?

Authors:  J E Roulston; A Gold; M Wright; S W Walker
Journal:  J R Soc Med       Date:  1987-08       Impact factor: 5.344

2.  Comparison of serum angiotensin-converting enzyme in Graves' disease, toxic nodular goiter, and other thyroid conditions.

Authors:  H Czernobilsky; W Fiehn; R Ziegler
Journal:  Klin Wochenschr       Date:  1985-06-03

3.  Familial resemblance of plasma angiotensin-converting enzyme level: the Nancy Study.

Authors:  F Cambien; F Alhenc-Gelas; B Herbeth; J L Andre; R Rakotovao; M F Gonzales; J Allegrini; C Bloch
Journal:  Am J Hum Genet       Date:  1988-11       Impact factor: 11.025

Review 4.  A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme.

Authors:  Kenneth E Bernstein; Frank S Ong; Wendell-Lamar B Blackwell; Kandarp H Shah; Jorge F Giani; Romer A Gonzalez-Villalobos; Xiao Z Shen; Sebastien Fuchs; Rhian M Touyz
Journal:  Pharmacol Rev       Date:  2012-12-20       Impact factor: 25.468

5.  Increased angiotensin-converting enzyme activities in diabetes mellitus: analysis of diabetes type, state of metabolic control and occurrence of diabetic vascular disease.

Authors:  G Schernthaner; C Schwarzer; R Kuzmits; M M Müller; U Klemen; H Freyler
Journal:  J Clin Pathol       Date:  1984-03       Impact factor: 3.411

6.  Response of serum angiotensin converting enzyme, plasma renin activity and plasma aldosterone to conventional dialysis in patients on chronic haemodialysis.

Authors:  C Letizia; S Mazzaferro; S Morabito; A De Ciocchis; S Cerci; C D'Ambrosio; G A Cinotti; D Scavo
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

7.  Serum ACE Level in Sarcoidosis Patients with Typical and Atypical HRCT Manifestation.

Authors:  Shahram Kahkouee; Katayoon Samadi; Ali Alai; Atefeh Abedini; Lida Rezaiian
Journal:  Pol J Radiol       Date:  2016-09-23

8.  Prognostic Biomarkers of Sarcoidosis: A Comparative Study of Serum Chitotriosidase, ACE, Lysozyme, and KL-6.

Authors:  Laura Bergantini; Francesco Bianchi; Paolo Cameli; Maria Antonietta Mazzei; Annalisa Fui; Piersante Sestini; Paola Rottoli; Elena Bargagli
Journal:  Dis Markers       Date:  2019-03-03       Impact factor: 3.434

9.  Changes of plasma angiotensin-converting enzyme activity during hemodialysis.

Authors:  W S Koo; Y J Lee; H S Kim; S Y Kim; E J Choi; Y S Chang; Y S Yoon; B K Bang
Journal:  Korean J Intern Med       Date:  1987-01       Impact factor: 2.884

10.  Changes of serum angiotensin-converting enzyme activity during treatment of patients with Graves' disease.

Authors:  D S Lee; J K Chung; B Y Cho; C S Koh; M Lee
Journal:  Korean J Intern Med       Date:  1986-01       Impact factor: 2.884

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.